The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Mcloughlin Margaret since 2020.
This trader's CIK number is 1770823.
At the time of last reporting, Mcloughlin Margaret was the Director of Quince Therapeutics, Inc.. (stock ticker symbol QNCX).
Also see all insider trading activities at Quince Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | QNCX | 8,000 | $9,840 | 0 | $0 | 0 | $0 |
| 2021 | QNCX | 0 | $0 | 7,550 | $699,017 | 7,000 | $119,000 |
| 2019 | QNCX | 550 | $9,350 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-08-08 | QNCX | Buy | 8,000 | 1.23 | 9,840 |
| 2021-10-08 | CRTX | Sale | 1,000 | 88.93 | 88,930 |
| 2021-10-08 | CRTX | Option Ex | 1,000 | 17.00 | 17,000 |
| 2021-08-16 | CRTX | Sale | 6,000 | 96.62 | 579,696 |
| 2021-08-16 | CRTX | Option Ex | 6,000 | 17.00 | 102,000 |
| 2021-06-28 | CRTX | Sale | 550 | 55.26 | 30,391 |
| 2019-05-13 | CRTX | Buy | 550 | 17.00 | 9,350 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mcloughlin Margaret (Director of Quince Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.